A detailed history of Founders Financial Securities LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Founders Financial Securities LLC holds 16,799 shares of AZN stock, worth $1.27 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
16,799
Previous 13,823 21.53%
Holding current value
$1.27 Million
Previous $1.08 Million 2.14%
% of portfolio
0.1%
Previous 0.1%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

BUY
$63.2 - $79.58 $188,083 - $236,830
2,976 Added 21.53%
16,799 $1.1 Million
Q3 2024

Nov 12, 2024

BUY
$76.67 - $87.62 $88,707 - $101,376
1,157 Added 9.13%
13,823 $1.08 Million
Q2 2024

Aug 02, 2024

BUY
$66.81 - $80.83 $45,698 - $55,287
684 Added 5.71%
12,666 $987,000
Q1 2024

Apr 17, 2024

BUY
$61.03 - $69.57 $54,804 - $62,473
898 Added 8.1%
11,982 $811,000
Q4 2023

Feb 06, 2024

BUY
$61.89 - $69.28 $685,988 - $767,899
11,084 New
11,084 $746,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $234B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Founders Financial Securities LLC Portfolio

Follow Founders Financial Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Founders Financial Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Founders Financial Securities LLC with notifications on news.